TY - JOUR
T1 - Fatigue and quality of life in citrin deficiency during adaptation and compensation stage
AU - Okano, Yoshiyuki
AU - Kobayashi, Kyoko
AU - Ihara, Kenji
AU - Ito, Tetsuya
AU - Yoshino, Makoto
AU - Watanabe, Yoriko
AU - Kaji, Shunsaku
AU - Ohura, Toshihiro
AU - Nagao, Masayoshi
AU - Noguchi, Atsuko
AU - Mushiake, Sotaro
AU - Hohashi, Naohiro
AU - Hashimoto-Tamaoki, Tomoko
N1 - Funding Information:
This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ; grants from the Ministry of Health, Labor and Welfare of Japan ; and funds from Suyama Research Foundation .
PY - 2013/5
Y1 - 2013/5
N2 - Citrin-deficient children and adolescents between adult-onset type II citrullinemia and neonatal intrahepatic cholestasis by citrin deficiency do not have clear clinical features except for unusual diet of high-fat, high-protein, and low-carbohydrate food. The aims of the present study are to characterize fatigue and quality of life (QOL) in citrin-deficient patients during adaptation and compensation stage, and to define the relationship between fatigue and QOL. The study subjects were 55 citrin-deficient patients aged 1-22. years (29 males) and 54 guardians. Fatigue was evaluated by self-reports and proxy-reports of the PedsQL Multidimensional Fatigue Scale. QOL was evaluated by the PedsQL Generic Core Scales. Both scale scores were significantly lower in child self-reports (p< 0.01 and p< 0.05, respectively) and parent proxy-reports (p< 0.01 and p< 0.01, respectively) than those of healthy children. Citrin-deficient patients with scores of 50 percentile or less of healthy children constituted 67.5% of the sample for the Fatigue Scale and 68.4% for the Generic Core Scales. The PedsQL Fatigue Scale correlated with the Generic Core Scales for both the patients (r = 0.56) and parents reports (r = 0.71). Assessments by the patients and their parents showed moderate agreement. Parents assessed the condition of children more favorably than their children. The study identified severe fatigue and impaired QOL in citrin-deficient patients during the silent period, and that such children perceive worse fatigue and poorer QOL than those estimated by their parents. The results stress the need for active involvement of parents and medical staff in the management of citrin-deficient patients during the silent period.
AB - Citrin-deficient children and adolescents between adult-onset type II citrullinemia and neonatal intrahepatic cholestasis by citrin deficiency do not have clear clinical features except for unusual diet of high-fat, high-protein, and low-carbohydrate food. The aims of the present study are to characterize fatigue and quality of life (QOL) in citrin-deficient patients during adaptation and compensation stage, and to define the relationship between fatigue and QOL. The study subjects were 55 citrin-deficient patients aged 1-22. years (29 males) and 54 guardians. Fatigue was evaluated by self-reports and proxy-reports of the PedsQL Multidimensional Fatigue Scale. QOL was evaluated by the PedsQL Generic Core Scales. Both scale scores were significantly lower in child self-reports (p< 0.01 and p< 0.05, respectively) and parent proxy-reports (p< 0.01 and p< 0.01, respectively) than those of healthy children. Citrin-deficient patients with scores of 50 percentile or less of healthy children constituted 67.5% of the sample for the Fatigue Scale and 68.4% for the Generic Core Scales. The PedsQL Fatigue Scale correlated with the Generic Core Scales for both the patients (r = 0.56) and parents reports (r = 0.71). Assessments by the patients and their parents showed moderate agreement. Parents assessed the condition of children more favorably than their children. The study identified severe fatigue and impaired QOL in citrin-deficient patients during the silent period, and that such children perceive worse fatigue and poorer QOL than those estimated by their parents. The results stress the need for active involvement of parents and medical staff in the management of citrin-deficient patients during the silent period.
UR - http://www.scopus.com/inward/record.url?scp=84876077224&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84876077224&partnerID=8YFLogxK
U2 - 10.1016/j.ymgme.2013.01.020
DO - 10.1016/j.ymgme.2013.01.020
M3 - Article
C2 - 23453692
AN - SCOPUS:84876077224
VL - 109
SP - 9
EP - 13
JO - Biochemical Medicine and Metabolic Biology
JF - Biochemical Medicine and Metabolic Biology
SN - 1096-7192
IS - 1
ER -